ADVERTISEMENT

Is AnnexinA1 The Miracle Drug For Diabetes?

Type-1 diabetes is a genetic disease which develops as a result of auto-immunity against insulin-producing cells in the pancreas. Essentially immune cells, which are designed to attack foreign pathogens (bacteria and viruses) attack cells from their own body. This leads to a destruction of insulin-producing cells, and a subsequent lack of insulin production, eventually leading the patient developing high levels of glucose in their blood.

This has very serious implications for the patientsā€™ health. In the immediate short term, they can enter into a diabetic coma, as a direct result of elevated blood glucose, which can be fatal. In the long term and even when patients undergo rigorous insulin replacement therapy to maintain normal blood insulin levels which lower blood glucose levels patients develop serious secondary complications. These complications are collectively known as microvascular complications and include diabetic nephropathy and diabetic cardiomyopathy. Currently, there are few medications available that are specifically designed to protect against the development of these complications. Additionally, there is little understanding of the mechanismā€™s that drive them although excessive inflammation is thought to be a key driver.

ADVERTISEMENT

Currently, there are no therapeutic strategies aimed at reducing inflammation in diabetes. In the last century steroids were shown to have therapeutic benefits in diabetes, but, due to their severe side effects could not be utilized in patients. Additionally, steroids themselves have been shown to induce a diabetic-like syndrome after long-term use. Annexin-A1 is an anti-inflammatory molecule produced in the body and is upregulated after steroids administration. Therefore, we foreseeĀ that annexin-A1 could have natural protective properties against the development of microvascular complications (which are caused by increased inflammation). Moreover, annexin-A1 could be harnessed as a therapeutic, with the same beneficial effects as a steroid but without the negative ones.

In our recent work, we have shown that annexinA1 is elevated in the blood of patients with type-1 diabetes compared to healthy controls. Interestingly, patients with diabetes and diabetic nephropathy (a severe complication of diabetes) did not have a further elevation in serum annexinA1, this was further compounded by the lack of correlation between annexin-A1 and C-reactive protein (a marker of systemic inflammation) together these results suggested that the increase in annexinA1 seen in diabetic patients was indeed associated with having type-1 diabetes. This prompted us to further investigate the role of annexinA1 in type-1 diabetes and the subsequent development of microvascular complications.

To do this, we used a well-established mouse model of type-1 diabetes that uses a chemical called streptozotocin to deplete beta cells rendering the mice unable to produce insulin and developing hyperglycemia. Additionally, we also used an annexin-A1 global knock-out mouse model (a mouse that produces no annexin-A1) to determine if annexin-A1 protects against the development of microvascular complications in experimental diabetes. Indeed, we found that diabetic mice lacking annexinA1 developed more severe diabetes and subsequent cardiac and renal dysfunction.

Additionally, Purvis et al. demonstrated that if you give annexinA1 as a therapeutic you can protect the heart and kidney from functional decline. We went on to determine that the beneficial effects of treatment with annexinA1 were mediated through the re-activation of both the Akt pro-survival pathway and by reducing the pro-inflammatory and hypertrophic MAPK (JNK, p38, and ERK1/2) signaling pathways.

ADVERTISEMENT

These results demonstrate for the first time a role for annexinA1 in the disease progression of type-1 diabetes. Interestingly, this research opens up a new undiscovered avenue of research that could unblock a new drug target for the microvascular complication of diabetes. It is of note that annexinA1 has been highly extensively researched in many disease states including Multiple Sclerosis (MS), myocardial infarction (heart attacks) and sepsis. In all these studies the resounding theme is that endogenous annexinA1 plays a key protective role.

These findings are described in the article entitled Annexin A1 attenuates microvascular complications through restoration of Akt signalling in a murine model of type 1 diabetes, published in the journal Diabetologia. This work was led by Chris Thiemermman and Egle SolitoĀ from theĀ Queen Mary University of London

Comments

READ THIS NEXT

NASA Successfully Tests New Mini-Nuclear Fission Reactor, With Applications For Space Exploration

The National Aeronautic and Space Administration (NASA) recently announced that it has completed initial tests of a new miniaturized nuclear […]

Electrochemical Sensors For Clinical Diagnosis: Advantages Of The Miniaturization And Portability Of Devices

The diagnosis of a disease is of vital importance because early identification can help the treatment to conclude successfully. For […]

Bubble Letters: Learn The Bubble Alphabet

If you want to turn everything you write into something fun, you should try bubble letters. Learning how to write […]

Post-weaning Diet In Archaeological Human Populations

There are two unique evolutionary characteristics in human childhood. First, human children take a longer time to acquire the physical […]

Of Two Minds: Antibiotics And The Gut-Brain Axis

Scientists have known for several decades that the gut and the brain communicate bi-directionally. And newer evidence suggests that the […]

Using EEG To Predict TV Show Success

In recent years, television entertainment has become a dominant force in the cultural zeitgeist, attracting ever-growing audiences and revenues. Both […]

Hurricane Effects On Plant-Herbivore Networks In Tropical Dry Forests

Hurricane effects are increasing in recent times; every day we hear in the news reports of a new high-impact meteorological […]

Science Trends is a popular source of science news and education around the world. We cover everything from solar power cell technology to climate change to cancer research. We help hundreds of thousands of people every month learn about the world we live in and the latest scientific breakthroughs. Want to know more?